Live Analyst Rating Changes 24961 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Julien Blouin
GS

Julien Blouin

Wall Street Analyst
★★★☆☆
#1307
on 13Foresight · ranked by our own returns
57%
Success Rate
+2.2%
Average Return
26 of 46 calls profitable · +33.9% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 57% of Julien Blouin's ratings turned a profit when each position was held for 1 year — averaging +2.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

26 Buy 20 Hold 13 Sell
Julien's Stock Coverage 19 ratings · 2026-08-16
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
NHP
National Healthcare Properties
Aug 05, 2026 BUY Buy
+8.9% avg upside
8 analysts
$22.00
34.20% Upside
+2.2% ·
JAN
Janus Living, Inc. Class A
Aug 04, 2026 HOLD Strong Buy
+2.1% avg upside
11 analysts
$32.00
4.54% Upside
+2.6% ·
TSE:CIGI
Colliers International Group
Aug 03, 2026 HOLD Strong Buy
+33.9% avg upside
16 analysts
$155.42
6.61% Upside
+4.8% ·
ARE
Alexandria Equities
Aug 03, 2026 HOLD Hold
+53.4% avg upside
26 analysts
$52.00
7.96% Upside
-8.8% ·
JLL
Jones Lang Lasalle
Jul 30, 2026 BUY Buy
-19.1% avg upside
17 analysts
$452.00
20.52% Upside
-1.3% ·
NMRK
Newmark Group
Jul 30, 2026 BUY Strong Buy
+24.9% avg upside
12 analysts
$21.00
37.66% Upside
+1.5% ·
CPT
Camden Property
Jul 30, 2026 SELL Buy
+8.8% avg upside
31 analysts
$103.00
6.69% Downside
+2.6% ·
UDR
UDR
Jul 30, 2026 SELL Buy
+18.9% avg upside
32 analysts
$38.00
0.22% Upside
+14.7% ·
AMH
American Homes
Jun 16, 2026 HOLD Strong Buy
+8.9% avg upside
31 analysts
$35.00
2.77% Upside
+5.1% ·
MAA
Mid-America Apartment
Jun 16, 2026 HOLD Buy
+12.3% avg upside
38 analysts
$132.00
1.02% Downside
-1.0% ·
ESS
Essex Property
Jun 16, 2026 HOLD Buy
+0.5% avg upside
35 analysts
$288.00
0.20% Upside
+3.4% ·
INVH
Invitation Homes
Jun 16, 2026 BUY Strong Buy
+19.2% avg upside
34 analysts
$32.00
5.63% Upside
+5.5% ·
CBRE
CBRE Group
Jun 10, 2026 BUY Strong Buy
-8.7% avg upside
24 analysts
$183.00
19.69% Upside
+14.0% ·
CWK
Cushman & Wakefield
Jun 04, 2026 BUY Buy
+12.8% avg upside
17 analysts
$17.00
18.12% Upside
+8.5% ·
VTR
Ventas
Jun 03, 2026 BUY Strong Buy
-9.8% avg upside
35 analysts
$110.00
20.28% Upside
+16.5% ·
OHI
Omega Healthcare
Jun 02, 2026 BUY Buy
-5.3% avg upside
30 analysts
$63.00
35.49% Upside
+5.2% ·
MRP
Millrose Properties Inc Class A
May 28, 2026 BUY Strong Buy
+22.0% avg upside
6 analysts
$35.00
15.40% Upside
+10.6% ·
DOC
Healthpeak Properties
Jan 09, 2026 HOLD Buy
+14.9% avg upside
43 analysts
$17.00
18.26% Downside
+29.3% ·
EQR
Equity Residential
Sep 04, 2024 HOLD Buy
+10.7% avg upside
38 analysts
$81.00
22.75% Upside
-9.7% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Julien Blouin — Frequently Asked Questions
How accurate are Julien Blouin's stock ratings?
Based on the calls 13Foresight could measure, about 57% of Julien's ratings were profitable over a one-year hold, with an average return of +2.2% per rating, or -2.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Julien ranked on 13Foresight?
Julien Blouin is currently ranked #1307 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Julien cover?
Julien most recently has ratings on NHP, JAN, TSE:CIGI, ARE, JLL, NMRK, CPT, UDR, AMH, MAA, ESS, INVH and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.